SCHEMBL9749902

SCHEMBL9749902

CC(C)(C)NCC(O)COc1nsnc1CCC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.52
BLM P54132 1/20 0.52
ADRB2 P07550 7/20 0.51
ADRB1 P08588 6/20 0.51
ADRB3 P13945 5/20 0.51
CYP2D6 P10635 3/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
HTR1A P08908 1/20 0.51
NFKB1 P19838 1/20 0.51
DRD1 P21728 1/20 0.51
SIGMAR1 Q99720 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
CASR P41180 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9749804 0.89 ADRB2 (0.50) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL9749811 0.86 ADRB2 (0.47) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL9749846 0.84 ADRB2 (0.43) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL11753865 0.82 CYP2D6 (0.57) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL11753852 0.82 CYP2D6 (0.57) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL9749858 0.81 SMN1; SMN2 (0.49) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL9749874 0.80 SMN1; SMN2 (0.34) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL9749852 0.80 ADRB2 (0.41) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL11403374 0.79 CYP2D6 (0.59) SMN1; SMN2BLMADRB2ADRB1ADRB3
SCHEMBL11758160 0.79 CYP2D6 (0.59) SMN1; SMN2BLMADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP claimed